A Randomized, Open-label, Active-controlled, Multiple Dose Phase 1 Clinical Trial to Evaluate Safety, Tolerability, and Pharmacodynamics of Tegoprazan After Oral Administration in Healthy Male Volunteers
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Tegoprazan (Primary) ; Revaprazan
- Indications Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections
- Focus Pharmacodynamics
- Sponsors CJ HealthCare; HK inno.N
- 01 Nov 2020 Primary endpoint (Serum gastrin concentration) has not been met as per results published in the Alimentary Pharmacology and Therapeutics
- 01 Nov 2020 Primary endpoint (Gastric pH) has been met as per results published in the Alimentary Pharmacology and Therapeutics
- 01 Nov 2020 Results published in the Alimentary Pharmacology and Therapeutics